Trial Profile
A phase III trial of SB-204 in patients with acne vulgaris
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 28 Nov 2021
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Acne vulgaris
- Focus Registrational; Therapeutic Use
- 10 Nov 2021 According to a Novan Inc. media release, potential submission of an NDA targeted for 2024.
- 10 Nov 2021 According to a Novan Inc. media release, the company expect to initiate this study in 2023.
- 13 Nov 2017 New trial record